BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10119050)

  • 1. Increasing women's participation in Pap smear screening in Australia--how can we tell if the national policy is effective?
    Shelley J; Street A
    Aust Health Rev; 1992; 15(2):190-9. PubMed ID: 10119050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of laboratory reports to assess cervical cancer screening in a community.
    Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
    Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions about Pap tests: what influences women and providers?
    Fiebig DG; Haas M; Hossain I; Street DJ; Viney R
    Soc Sci Med; 2009 May; 68(10):1766-74. PubMed ID: 19339094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.
    Bowman JA; Redman S; Dickinson JA; Gibberd R; Sanson-Fisher RW
    Health Serv Res; 1991 Apr; 26(1):97-107. PubMed ID: 2016170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer.
    Belkar R; Fiebig DG; Haas M; Viney R
    Health Econ; 2006 Jan; 15(1):33-47. PubMed ID: 16145719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young women and cervical cancer screening: what barriers persist?
    Black AT; McCulloch A; Martin RE; Kan L
    Can J Nurs Res; 2011 Mar; 43(1):8-21. PubMed ID: 21661613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing women's compliance with opportunistic cervical cancer screening: a randomized trial.
    Ward JE; Boyle K; Redman S; Sanson-Fisher RW
    Am J Prev Med; 1991; 7(5):285-91. PubMed ID: 1790034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap smear tests in general practice. An update.
    Ward J; Sanson-Fisher R
    Aust Fam Physician; 1992 Apr; 21(4):465-6. PubMed ID: 1530474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health.
    Blackwell DL; Martinez ME; Gentleman JF
    Womens Health Issues; 2008; 18(2):85-99. PubMed ID: 18182305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family practice residency cervical screening project: perceived screening barriers.
    Branoff R; Santi K; Campbell JK; Roetzheim R; Oler M
    Fam Med; 1997 Feb; 29(2):119-23. PubMed ID: 9048173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a cognition-emotion focused program to increase public participation in Papanicolaou smear screening.
    Park S; Chang S; Chung C
    Public Health Nurs; 2005; 22(4):289-98. PubMed ID: 16150010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
    Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of letters to Cape Breton women who have not had a recent Pap smear.
    Johnston GM; Boyd CJ; MacIsaac MA; Rhodes JW; Grimshaw RN
    Chronic Dis Can; 2003; 24(2-3):49-56. PubMed ID: 12959674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in ethnocultural groups: case studies in women-centered care.
    Bottorff JL; Balneaves LG; Sent L; Grewal S; Browne AJ
    Women Health; 2001; 33(3-4):29-46. PubMed ID: 11527105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of cervical cancer screening in The Netherlands is mainly influenced by women's beliefs about the screening and by the inviting organization.
    Tacken MA; Braspenning JC; Hermens RP; Spreeuwenberg PM; van den Hoogen HJ; de Bakker DH; Groenewegen PP; Grol RP
    Eur J Public Health; 2007 Apr; 17(2):178-85. PubMed ID: 16837520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hispanic acculturation and utilization of cervical cancer screening in the US.
    Shah M; Zhu K; Wu H; Potter J
    Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.